ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000222.1|FD-594_1 # 3 # 512 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGAGA;rbs_spacer=10bp;gc_cont=0.731	BGC0000222.1|FD-594_1 	3	512	-	Loose	375	26.5646	tmrB	32.14	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	ATGAGCGACACTCCCCGCATCGGCTACGGCCAGATCCGCTTCCACCTCCTCGACCTCCTCGGCCAGCGGCCACGGCACGGCTACGAACTGCTCGCCGCCCTCAGCGACAAGTTCGCGGGCACCTACCGCCCCTCCCCCGGCGCCGTCTACCCCAGGCTGCGCCGTATGGAAGCCGAAGGGCTCATCCGCCACGAAGACGTCAGGGGCCGGAAGGTCTACCACCTCACCAGCGCCGGCCGGCAACAGCTCACCCACCAGGAACCGGCGGACGCCCGGCCCGGGACGGAGGACGAAGACGGCGGCGAGCGGACCCCGCCGCCCCCCGCTCCCGTCGGCGGGCTCAGCGAAGCCATCCGCAGCGACGTCGAGAGCATCGTCCGCGATTTCCGCCGGCAGTTCACCACGGCCATGGACCGCCCGGCCCGCACCTCCGACGAACGCGACTGGCTCGGCTGGGCGGCCTGGCCCACCCCGCCCCCGCCGCAGCGCACCCCAGACACCCGTCAGAAT	MSDTPRIGYGQIRFHLLDLLGQRPRHGYELLAALSDKFAGTYRPSPGAVYPRLRRMEAEGLIRHEDVRGRKVYHLTSAGRQQLTHQEPADARPGTEDEDGGERTPPPPAPVGGLSEAIRSDVESIVRDFRRQFTTAMDRPARTSDERDWLGWAAWPTPPPPQRTPDTRQN	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	86.29	gnl|BL_ORD_ID|1654|hsp_num:0	1794			183	339	tunicamycin
BGC0000222.1|FD-594_3 # 1494 # 1943 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.693	BGC0000222.1|FD-594_3 	1494	1943	-	Loose	210	37.3502	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	36.96	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCCGCCTCAGCGGTGAGACCGTGCTGTTCCACCAGGCGATCGCCGACCGGCTCGGGATCAACCCCACCGACCTCAAGTGCCTGGACCTGGCCTCCGGCCCCGAGCCGGTCACCGCGGGCCGGCTGGCCGAGGTCTCCGGGCTCACCTCGGGCGCGATCACCGGAGTGATCAACCGCCTGGAGAAGGCCGGGCTCGTCGAGCGGCAGCCGGATCCGGACGACCGCCGCAAGGTGATCATCGCCGTCCGCCCGGACGTGCCCATGACCGTGATGGGCCTGTTCGGCTCCATGTCGCACTCGATGCTGGAGCTGTGCTCCCGCTACGAGGAGCACGAACTCGCCCTGGTCCTGGACTTCGTCAGCCGCGCGGCGGACACCATGCACTCCGAGGCGATCAAGCTGCAGGAGAAGACGGAGAAGCCCGGGAAGCCCACCGTCGACGCCTGA	MRRLSGETVLFHQAIADRLGINPTDLKCLDLASGPEPVTAGRLAEVSGLTSGAITGVINRLEKAGLVERQPDPDDRRKVIIAVRPDVPMTVMGLFGSMSHSMLELCSRYEEHELALVLDFVSRAADTMHSEAIKLQEKTEKPGKPTVDA	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	103.47	gnl|BL_ORD_ID|1984|hsp_num:0	431			162	300	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000222.1|FD-594_4 # 2247 # 4040 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.703	BGC0000222.1|FD-594_4 	2247	4040	+	Loose	1050	362.073	facT	42.83	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACTGCAATCCATACGGATCTGGCGGCCGAACCGGGCGGCGGCGGATCCCGGGAATCCCGGCGGTGGTGGGCGGTCCTCGCACTGCTCCTGGCCAGCTTCATGGACCTGCTGGACGGGACCATCGTCAACGTGGCCATCCCGTCGCTGCAGAGGGACCTCGGGACCAGCAACTCCGACGCGCAGTGGGTGGCGTCCGGCTACGCGCTGGCGTTCGCGCTGGTGCTGATCACCGGGAGCCGGCTCGGGGACATCTTCGGCCGCAAGAACCTGTTCCTGATCGGCGTCGCGGGCTTCGTGGTGACCTCGGCCCTGTGCGGAGCGGCGCAGGGCCCGGGGATGCTGATCGCGGCCCGCGTGCTCCAGGGAGCCGTGGCCGCGCTCATGGTGCCCCAGGTGCTCTCCACGCTGATGGCGACGTTCCCGCCCAAGCAGGGAGCCATGGTCGCCGGCATGTTCGGCGGGGTGTCCGGCCTGGCCGTGGTCAGCGGGCCGCTGCTCGGAGCGCTGCTGATCAAGGCCGACCTGCTGGGGCTGGAATGGCGGACGATCTTCCTGGTGAACGTCCCGGTGGGGATCGCCACGCTCGTCGTCGCGGCCCTGTTCGTGCAGAACACCAAGTCGGAGCACGCCCAGCGGGTGGACGTGCTGGGCAGCGCGCTGGTGACGGTGGCGATGCTGCTGCTGATGTACCCCCTGCTCAAGGGCCGGGACCTGGGGTGGCCGGTGTGGACGTACGTGTCCATGGCCATGTCCGTTCCGATGCTCGCCCTGTTCGCCTACGTCCAGATCCGGAAGGGCCGTGACCACCGCTCCCCGCTGGTCGAGATGAGCCTGTTCCGCAAGGGTCCCTTCAACGGCGGGCTGATCATCGGCTTCCTGTTCTTCGCCGCGCTGATCGGCTTCTTCTTCGTCTTCATGCTGTACCTGCAGATCGGGCGCGGCTTCACGGTCCTGCACGCGGGTCTGACCGCGCTGCCGTGGTCGCTGGGCATGGCGATCGGATCGGCGGTCTCCGGCGCGGTGCTCGCCCCCCGGCTCGGCCGGAAGCTGCTGAGCATCGGCGCGCTGGTGATGGCCGTCGCGTTCACCTCCCTGAGCCTGACGCTGCACTACCAGGGCACGAGCGCCACGTCCTGGCAGATGCTGCCCAGCCTGCTGGTGGCCGGCCTGGGCATGGGGGCCGTGGTCTCCACCCTGTTCAGCATCGTGCTGGCGGCGGTGGAGCCCCGTGAGATCGGCTCGGCCTCGGGCCTGCTCAACGCCATCACCCAGGTGGGAGCCTCGGCCGGCGTCGCGATCCTCGGTGTCGTGCTCTTCTCGCTGCTGGGCTCCCAGTCCACCGACATGGCGGACCGGGCGGCGCCCCGGCTGAGGGCCGAACTCTCGGCGGCGCACGTACCCGGACCCGTCCAGGACCAGGTGATCGCGAAGTTCCGGTCCTGCTACCACGACCGGATGGCGGCGAAGGACCAGTCCGTGGCACCGGCCGGCTGCGGCGGTGCCGAGCCGGGCGGCGGCGATTCCGCCCCGCCGCAGCGGGTGAGCAAGGAGGTGACGGAGGCGCTGGAGCACGCGGGCGCCACGACCAACGGCAAGAACTTCACCCTCGCCCTCGAACGCAGCCTGTGGGCGCGGCCGGGGCCATGGTGCTGGTCTTCTGCCTGTCCTTCATCCTCCCGCCCCGCGCACGCAGCTGGGGCTGATCACAGCAGCGCTCGCAGCAGCATCCGCAACACCCGCAGCAGCACTGATCGTCGTGGCCGGGCTTCCGGCCACGACGATCGGCGTTGA	MTAIHTDLAAEPGGGGSRESRRWWAVLALLLASFMDLLDGTIVNVAIPSLQRDLGTSNSDAQWVASGYALAFALVLITGSRLGDIFGRKNLFLIGVAGFVVTSALCGAAQGPGMLIAARVLQGAVAALMVPQVLSTLMATFPPKQGAMVAGMFGGVSGLAVVSGPLLGALLIKADLLGLEWRTIFLVNVPVGIATLVVAALFVQNTKSEHAQRVDVLGSALVTVAMLLLMYPLLKGRDLGWPVWTYVSMAMSVPMLALFAYVQIRKGRDHRSPLVEMSLFRKGPFNGGLIIGFLFFAALIGFFFVFMLYLQIGRGFTVLHAGLTALPWSLGMAIGSAVSGAVLAPRLGRKLLSIGALVMAVAFTSLSLTLHYQGTSATSWQMLPSLLVAGLGMGAVVSTLFSIVLAAVEPREIGSASGLLNAITQVGASAGVAILGVVLFSLLGSQSTDMADRAAPRLRAELSAAHVPGPVQDQVIAKFRSCYHDRMAAKDQSVAPAGCGGAEPGGGDSAPPQRVSKEVTEALEHAGATTNGKNFTLALERSLWARPGPWCWSSACPSSSRPAHAAGADHSSARSSIRNTRSSTDRRGRASGHDDRR	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	106.80	gnl|BL_ORD_ID|1345|hsp_num:0	1469			72	1527	factumycin
BGC0000222.1|FD-594_5 # 4068 # 4970 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.732	BGC0000222.1|FD-594_5 	4068	4970	-	Loose	450	25.0238	APH(3'')-Ic	45.45	3002640	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	GTGCCCTCCAGCGACGCGCTAGCCCCCGTGGACAGCATCGTCGTCACGCTACGGAATGCCTGCGGCCTGCCGGCCCGGTTGCGCGCAGGCACCCGCGAGACGAGGTGGCATGGGATGGTGACCTACACATCGGCCCTGGTGACCGGGGCCTCCAGCGGCATCGGGCAGAGCCTGGCCAGGTGCCTGGCGGCGCAGGGGACCGGTGTCGTGGTCGTGGCCAGGCGCGGCGACCGCCTGGAGCGGCTGGCCGAGGAGCTGCGCGGGCGCTACGAGGCGTCCGTCGAGGTGCTGGCGGCCGACCTGTGCGTACCGGAGGACCTGGCCGGCGTGACGAAGCGGCTGACCGACCCGGACCGGCCGATCGACCTCCTGGTCAACAACGCCGGGGCGGGTTCCCGGCCTCCGCGGCCGCTCGCGGACCAGCCGCTGGACCACGAGCTGGGCAAGGTGGAGCTGAACGTGCTGGCCCCCCTGCGGCTGACGCACGCGGCGCTGTCCGTGATGATCCCCCGGCGGCACGGCGGAATCCTCAACGTCTCGTCGATCGCCGGTTTCCTCCCGCAGCCCCAGGGCGCGACGTACGCGGCCACGAAGGCCTTCCTGACCTCCATGACGGAGACGGTGTACTGCGAGGCCCGCAAGTCGGGTGTCCACGCCACCGTGGTCTGCCCCGGTTTCGTACGGCGGGGTGAGGGCGGGGCGGACGGCGGGATGCGCAGCCTCCGCCTTCCGGAGTTCGCCTGGCTGGACCGGGACGAGGTGGCCCGCGAGGCGATCCGGGCGGTGCGCGCCGGCAAGCCCGTGTGCATCCCGGGGTGGCAGTACCGGACGGCCATCACGCTGAGCCGGGTGCTGCCACGGGCGCTGTCCCGCACGGGGTTCGAGCGTTTGTGGGGACGCTGA	MPSSDALAPVDSIVVTLRNACGLPARLRAGTRETRWHGMVTYTSALVTGASSGIGQSLARCLAAQGTGVVVVARRGDRLERLAEELRGRYEASVEVLAADLCVPEDLAGVTKRLTDPDRPIDLLVNNAGAGSRPPRPLADQPLDHELGKVELNVLAPLRLTHAALSVMIPRRHGGILNVSSIAGFLPQPQGATYAATKAFLTSMTETVYCEARKSGVHATVVCPGFVRRGEGGADGGMRSLRLPEFAWLDRDEVAREAIRAVRAGKPVCIPGWQYRTAITLSRVLPRALSRTGFERLWGR	MTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDWRVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDMLARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCLPNILVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADTVPGFAEEATAGLAAGYPAQVDPERLRFYLALDPLTWG	118.11	gnl|BL_ORD_ID|1889|hsp_num:0	2052			450	558	streptomycin
BGC0000222.1|FD-594_7 # 5758 # 6387 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGGA;rbs_spacer=6bp;gc_cont=0.705	BGC0000222.1|FD-594_7 	5758	6387	+	Loose	400	28.8758	Erm(K)	26.19	3004643	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAACCATGGCTCTACACACTGCTGTACAAGCGAGGCGCCGCATGGGAGCACGTCGGAGTCAGCCCCGAACTGCGCGGACTCCTCGCCGAGGGGAGGATCGCCGCCCCCGTGTCGCCCGCCGGCCGTNCGCGCGCCCTCGACCTGGGCTGCGGCACCGGAGCGAACGCGGTGTTCCTCGCGCAGAACGGCTTCGACGTCGTGGGCGTCGACTTCACCGAGTACGCCCTCCAGCGCGCACGCGAACGCGCCCGTGAGGCAGCGGTCGAGGACCACTGCCGCTTCGTCAACGCCGACCTGTCCTCCCCGCGCATCCCCGGCGTCGAGGGCCCCTTCGACCTGCTGATCGACTACGGGACCCTGGACGACACCACCGGGCCCGTACGCCGGGGCATGGTGAACACCGTGCTGCGGCTCTCGCGCACGGGGACGCAGTTCTTCCTCTGGTGCTTCTCGGCGGACAAGAAGGACCTGCCGCTGGTGGCCCGCCGGAGAATGTCCCGGCTGCTCCACACGGTCATGGCGCCGGGAGAGGAACAGCGCCTGTTCGGCCACGCCTTCGACATCGAGCGGCTTCCCGATCCGCCCCGGCCCGAGCACGCCGCCTGCTTCCTGATGGTGCGCCGCTGA	MKPWLYTLLYKRGAAWEHVGVSPELRGLLAEGRIAAPVSPAGRXRALDLGCGTGANAVFLAQNGFDVVGVDFTEYALQRARERAREAAVEDHCRFVNADLSSPRIPGVEGPFDLLIDYGTLDDTTGPVRRGMVNTVLRLSRTGTQFFLWCFSADKKDLPLVARRRMSRLLHTVMAPGEEQRLFGHAFDIERLPDPPRPEHAACFLMVRR	MTKKKHKYSNKKLSRGEPPNFSGQHLMHNKKLLQEIVDQAKVSKKDTVLELGAGKGALTTFLSERAKRVLAVEYDQTFIQVLNRKMAHAANTTIIHEDIMRIHLPKGEFVVVSNIPYSITTPIMKKLLSNPVSGFQRGVIVMEKGAAKRFTSPFIKNAYVLAWRMWFDLEYVKGISRECFSPPPKVDSAMVFISRKPDPIVPYKDRSAFFGLAEYALREPKAPADSLLRGIFTATQLKHVKRNAGIKHDVSIGALSERQWGVIFETMTQYVRRPLWPRPRKTTL	73.59	gnl|BL_ORD_ID|2122|hsp_num:0	3341			87	324	erythromycin
BGC0000222.1|FD-594_8 # 6558 # 8465 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=8bp;gc_cont=0.675	BGC0000222.1|FD-594_8 	6558	8465	+	Loose	400	37.7354	vanR gene in vanN cluster	33.33	3002929	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCGATTCAGCATTCTCGGCAGCCTTGAAGTCTACAGTGGTGACACGCTGGTAACTCCGACCTCGCCCAAGCTGCGCCACGTACTGGCGGCGCTGATCCTGCATGCGAATCAGCCCGTACGGCCGGCATCCCTCATCGAAGAACTGTGGCACGAGCCCCCCGCCAGTGCCGCCACCACCCTCCAGACCTACATATACCGGCTGAGGAAGAAACTCGGCGCTTATCAAAGGGCCGAAGAGGAACGGGAAGTTCTGGTTACGATCAATTCGAGTTACCTGGTGCGCACCCGGGCCGACCAGCTCGACCTGAACCTGTTCGAGCGGCTCTCCCACCAGGGGCGTGAGGCATTGCAGGACGGAAGGCCGGACCAGGCGTCCTCCCTGCTCGACGAGGCGCTGTCGCTGTGGCGGGGGAAGATGCTGGACGGCGTCTCCGTCGGGCCGCTCCTGGAAGCGCATCTGGTCCGTTTCGAGGAAGCCCGGCTGCGAGCCTTCGAAATGCGGATGGAGGCCGGCCTGCAACTGGGCCGCCACCACGAACTGATCGCCGAGCTCAAGGCCCTGACCACCAGTCATCCCCTGCACGAGGGGTTCCCCGCCCAGCTCATGCTGGCCCTGTACCGCTCGGACCGCCGGCTGGAGGCCCTGGAGGTCTACCGTTCGCTGCGCCACCGGCTCGTCAGCGAACTCGGAGTGGAGCCGTCCGGTGAGCTGGTGCAGCTCCACCAGACCATCCTGCGTGCCGATCCGTCGCTGAACCTCCCCAGCGGCAACCATTCCGTCGTCCAGCTGCGGAGCGCGCCCGCGCAACTGCCGGTCAAGGCAGGGCCGGTGATGCACCAGGAGCGCGCGGTGCAGCTGGAGGCGCTGCTACGGGCCACGACCTCCGGCAGGCGCGGCTCGTCCCTGCCTCGCGTGGTGTCGCTGCACGGCATGGCGGGAGTGGGCAAGAGCGAGCTGGCCCTGCACGTGGCCCACCAGCTGCGTTCCCACTTCCCGGACGGTCAGCTCTACGCCGATCTCCGGGATCTGCAAGGCCACTTGGTCCGCCCCTTCGAGGCGATCGCCGGTTTTCTCCGGGCGGCCGGAGTACAGCCGGAACGATTCGGCAGGCTGGAGGAGCGGAGGGAACGGTTTCGCTCCTGGAGCGCGGACCGCAAGGTGCTGATCATCCTCGACAACGCCGAGTCGCCCGAACAGGTGCTGCCGCTCCTGCCCGGCGGCCCGGACTGCGTGACCGTCGTCAACAGCCGGTCCCGGCTGGCGGGGCTGCGCGACGAGGTGGCCCTGGAACTCTCCCCGCTCTCGGCCGACGAGGGGATCCAGTTGCTGGAGTCCCTGCTTTCCGACGGGCACGGGCTGCCGGACCGCGAGCTGGCCGAACAGGTGGTCAGGCTGTGCGGCTTTCTGCCGGCCGCCATCTGCGCGGCGGCGTTCCAGCTCAGTGCCCGGCCGCAGTGGGGCCTGCGCGATCTCGCCGACTGGCTGACGCATTCCGAGGGCCGCCTGACCTTCCTGACGTCACCGGAGGTGAGTCTGCACAAATCCTTCGAGCTGAGCTGCCGCAAGCTGGGGCAGACCGGCCTTCAGATCTTCGAACAACTCGCCTCCCTGCCCGAGACCTTCACCCGCGAAGACCTCCTGGTGGAGGACGACGTCGCCGACAGGGCGCTCAAACAACTGGTGGAATGCAGGTTGCTGGAAGAAGTCGTGCAGGTGGTCGGCGGAAGTTACCGGCCCGCGTACCGCTGTCACGAACTGGTCCGCCTTTACGCACGGGAACGCCTGATGTCGGCAAAGGGACGCCTACGGGCGGCGCGTCGGGCGCGGCTCCGGTCCGGCGCCGACTGCTTCCGCCCTTTAAGCGGCCTTACGGTGCCGGGCTCCGGGCAACTGGTAATGGAGTGA	MRFSILGSLEVYSGDTLVTPTSPKLRHVLAALILHANQPVRPASLIEELWHEPPASAATTLQTYIYRLRKKLGAYQRAEEEREVLVTINSSYLVRTRADQLDLNLFERLSHQGREALQDGRPDQASSLLDEALSLWRGKMLDGVSVGPLLEAHLVRFEEARLRAFEMRMEAGLQLGRHHELIAELKALTTSHPLHEGFPAQLMLALYRSDRRLEALEVYRSLRHRLVSELGVEPSGELVQLHQTILRADPSLNLPSGNHSVVQLRSAPAQLPVKAGPVMHQERAVQLEALLRATTSGRRGSSLPRVVSLHGMAGVGKSELALHVAHQLRSHFPDGQLYADLRDLQGHLVRPFEAIAGFLRAAGVQPERFGRLEERRERFRSWSADRKVLIILDNAESPEQVLPLLPGGPDCVTVVNSRSRLAGLRDEVALELSPLSADEGIQLLESLLSDGHGLPDRELAEQVVRLCGFLPAAICAAAFQLSARPQWGLRDLADWLTHSEGRLTFLTSPEVSLHKSFELSCRKLGQTGLQIFEQLASLPETFTREDLLVEDDVADRALKQLVECRLLEEVVQVVGGSYRPAYRCHELVRLYARERLMSAKGRLRAARRARLRSGADCFRPLSGLTVPGSGQLVME	MDTIVIVDDEKEIANLMTTFLENEGFKVMTFYSGKEALDYIDQNGASLAILDVMLPDLDGFQILQHIRQTFFFPVLMLTAKGENLDKITGLTLGADDYITKPFNPLEVVARVKTQLRRTQRYDQPSHSQSDEEFTKEGLVLKKNSHQVFLFDQEVLITPLEFKILLYLFEHQGTVVSSETLFEEVWQEKYLDNNNTVMAHIARLREKLGEKPRKPKYIKTVWGVGYIIEK	276.09	gnl|BL_ORD_ID|4738|hsp_num:0	1219			447	627	vancomycin
BGC0000222.1|FD-594_9 # 8468 # 9724 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.726	BGC0000222.1|FD-594_9 	8468	9724	+	Loose	600	25.409	TriB	33.33	3003680	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATCAGCCGACAGAACCGCCCACCGACCCCACCGATCAGCCCACCACCCTGCCGTTTCCTTTCCCGGACACCGGGGACACCGGGGACATCAGAGGCACCGGACCGCTGGAGATAGCCGAGGAGTTCGCGCGGCTCCGCAGCGGCTGCCCGGTGGCCCGGGTCCGCTTCGCGACCGGGGACAGCGGCTGGCTGGTCACCCGCTACGACGACGTGCGCGCCGTGCTCACGGACGCCCGGTTCAGCCGGGCGGCCGCCGCGCTTCCCGGCGCCCCCCGGATGCGGCCGCTGGCCGCGGACGCGGCGACGATCCTGTCGATGGACCCGCCCGAGCACACGCGACTGCACAAGCTGGTGGCCCGCGCCTTCGGGAAGAAGCGGATCGAGCGGCTGCGGCCCTTCGTCGAGCGGACCGCCGAGGACCTCGTGGCCGCCATCGAGGAGACGGGCCCGCCGGCCGACCTGGTGGCGGGCCTGGGGCTGCCCCTGCCGATCGCCGTCATCTGCCATCTGCTCGGGGTGCCGTTCGCCGACCGGGACCGGTTCTGCCGCTGGGCCGACATCATGCTCAGCCTCGGCACCCACAGCCCCGGACAGGTCCAGGCGGCACGCGACGACCTGGCCGGCTACCTGGCCGACCTGATCGAGGCCAAACGCCGTACCCCGGGCGACGAGGATCTGCTGGCCATGCTGATCTCCGCCCGCGAGGACGGTGACCGGCTGAGCGAGCGCGAACTCGTCGTCTTCGGCGTCACCTTGCTGATCGCCGGCTACCACACGACGTCCAGCACACTGGCGGGCGGAGCCCTCCAGCTGCTGCGCCGGCCCGAGCTGACGGACCGGATCCGGGGCGATCAGCAGCGCATCCGGACGACGGTGGAGGAGATCCTCCGGTACAGCACCGCGGGCGTCAACGGCGGCACCATCAGGGTCGCCACGGAGGACGTCGAGCTGGGCGGGGTCCTGGTGCGGGCCGGGGAGGCCGTCCTGCCCGCGATCACCTCGGCCAACCGGGACGAGTCGGTCTTTGCCGGCGCCGCCGGCTTCGACCCTGGGCGCGAGGACAACCCGCACCTGGCGTTCGGCCTGGGCGTGCACTACTGTCTCGGCTCCCAGCTGGCCAGACTGGAACTGACCGTCGCGCTCGACAAGTTGCTCGACCGCCTGCCGGGGTTGCGCCTCGCCGTGCCGGAAGCGGAGCTGACGTGCACCCCGGGTGTCATCCGGAACCTGACCGCGCTGCCCGTGGAGTGGTGA	MDQPTEPPTDPTDQPTTLPFPFPDTGDTGDIRGTGPLEIAEEFARLRSGCPVARVRFATGDSGWLVTRYDDVRAVLTDARFSRAAAALPGAPRMRPLAADAATILSMDPPEHTRLHKLVARAFGKKRIERLRPFVERTAEDLVAAIEETGPPADLVAGLGLPLPIAVICHLLGVPFADRDRFCRWADIMLSLGTHSPGQVQAARDDLAGYLADLIEAKRRTPGDEDLLAMLISAREDGDRLSERELVVFGVTLLIAGYHTTSSTLAGGALQLLRRPELTDRIRGDQQRIRTTVEEILRYSTAGVNGGTIRVATEDVELGGVLVRAGEAVLPAITSANRDESVFAGAAGFDPGREDNPHLAFGLGVHYCLGSQLARLELTVALDKLLDRLPGLRLAVPEAELTCTPGVIRNLTALPVEW	MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR	117.42	gnl|BL_ORD_ID|2003|hsp_num:0	2193			267	393	triclosan
BGC0000222.1|FD-594_10 # 9809 # 10354 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGAGA;rbs_spacer=14bp;gc_cont=0.714	BGC0000222.1|FD-594_10 	9809	10354	+	Loose	300	24.2534	FosC	28.95	3000380	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosC phosphotransferase family	GTGACTGACGACACCAAACAACCGCACCTGCCGGAGCGGGTGAGGATCTCCGACGCGGAGCGGGAGCGACTGGCCGGCCGATTACAGGCCGCTGTGGGCGAGGGCCGCATCTCGTTCGCCGAGCTCGACCACCGCCTGTCCCTGCTCTACGCCGCCCGCACCCGCGAGCAGGCACAGGCGGTGGCGGCCGACCTCCCGTCCGCAGAGGCCCCGCGGTCGTTGCATCTGCGCCGGGTGAAGACGTTCTCCCGGATCGCCGGCCCCTGGGACGTCCCGGCCGTGCTGACCGTCGACGCCTACGACGCGGTGATCCGGCTGGACTTCCGCCACACGTCCATCGAGCACACCGAGGTGCGCATCGAACTCTGGGCGCACAAGAGCGTGGTGCGGCTGTGGCTGCCGGCCGGTTCGCCGGTCTCGGCGCACGAGCTCGTGACCCACAAGGCGTGGGTCCGCAACCGGCGCGCCGGGCAGCCGGGATCGCCCGACGGCGTCCGCTTCACGATCACCGGGGAGCTGTCGAAGGCGATGCTGTCGCTGCACTGA	MTDDTKQPHLPERVRISDAERERLAGRLQAAVGEGRISFAELDHRLSLLYAARTREQAQAVAADLPSAEAPRSLHLRRVKTFSRIAGPWDVPAVLTVDAYDAVIRLDFRHTSIEHTEVRIELWAHKSVVRLWLPAGSPVSAHELVTHKAWVRNRRAGQPGSPDGVRFTITGELSKAMLSLH	MMTSIMFSMLSDITRIFVEQGLRVYPFQSSALLGVDEEGRVTLHARQLATAMASGYMPLLTGDLLLRGEQEAQVFSSDNIAPLLAADFEVRRVLYYSDVAGVYDQGNALVPWVGNANAACMEACVGASSMTDLTGGMRNKFMQQRQLARLGVVSEVLSFECFDRVHLSLCGLRQFGTVFLSE	99.45	gnl|BL_ORD_ID|1117|hsp_num:0	1215			198	312	fosfomycin
BGC0000222.1|FD-594_14 # 13377 # 13901 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGGAG;rbs_spacer=8bp;gc_cont=0.718	BGC0000222.1|FD-594_14 	13377	13901	+	Loose	690	23.8682	MexJ	28.26	3003692	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCCCCGACGCGACCAAGGCGACCAAGCCGACGGCAACCAAGGCGACCGACGTGACCCCGGCACCCGAAGTGACCCAGGTGACGAACGTGACCAAGGTGGCCTTCACCGACATCAAGCCGAACCGGCGCAGGGGCGGCGACGTCCGCGTCCTGCTGAGCCCGCTGACGGCCGGTGCCACCTCGGGGTTCATGGGCACGGTGACGCTGGAGCCCGGCGAGCACGTCTGCGAGCACTACCACCCGTACTCCGAGGAGTTCGTCCACCTGGTCCGCGGGACCGTCGTGCTCACCATCGGCGGCACCACGCTCACCCTGGAGCCCGGGGACTCGGCCCTGGTCCCCATCGGTGTGCGCCACCGGCTGGTGAACGCCGGCTCTGTAGCGGCACAGGCCGTCTTCCATCTGGGGCCGCTGGCGCCCCGCCCGGAACTCGGCCACGTCGACACCGAGTTCCTGCCCGGCGCCCGCGACGAGCCCGTGCTCGAAGTCGGCGGAGGCGGAACCCCCGGGGCGGGCTCATGA	MSPDATKATKPTATKATDVTPAPEVTQVTNVTKVAFTDIKPNRRRGGDVRVLLSPLTAGATSGFMGTVTLEPGEHVCEHYHPYSEEFVHLVRGTVVLTIGGTTLTLEPGDSALVPIGVRHRLVNAGSVAAQAVFHLGPLAPRPELGHVDTEFLPGARDEPVLEVGGGGTPGAGS	MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE	47.41	gnl|BL_ORD_ID|2015|hsp_num:0	2205			720	990	erythromycin; tetracycline; triclosan
BGC0000222.1|FD-594_15 # 13898 # 15169 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.732	BGC0000222.1|FD-594_15 	13898	15169	+	Loose	200	27.7202	ANT(3'')-IIb	39.53	3004090	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGAGAACGATGGACGTCGCCATCACCGGCATCGGCGTCATGGCCCCCGGCGGGGCGGGCCGGGAGGCGTTCTGGGACTGCATCGTCTCCGGCCGCACGGCCACGCGCCGGGTCACCCACTTCGACCCGGCGGGCTACCGCTGCCAGGTGGCGGCCGAGATCGACTTCGACCCGGCCGCCCACGGGCTCACGCCGCAGCAGGCGCGCCGGATGGACCGGGCCGCCCAGCTCGCCGTCGTGGCCACGGACGAGGCGCTGGCCGACAGCGGCTTCGACACCGGGGGCACCGACCCCGGGCGGATCGCCGTGACCGTCGGCAACGCGGTCGGCTGCACCACCGGCCTGGAAGAGGAGTACCGCGTCCTCAGCGACGACGGCAGGCAGTGGGCCGTCGACCACACCTTCGCCGTTCCCCAGCTCTACAACTACCTGGTGCCCAGCTCGATCGCCACCGAGGTGGCCTGGCGCGCAGGGGCCGAAGGGCCGGTGTCGGTGGTCTCCTCCGGCTGCACCTCGGGCATCGACGCCCTCGGGTGTGCCGCCGGCCTCCTGGCCGAGGGCAGTGCCGACGTCGTCGTGGCCGGTTCCGCCGACGCGCCGATCTCGCCCATCACCATGGCCTGCTTCGACGCGATCAAGGCCACCTCCACCTACAACGACGACCCGCAGCAGGCCTGCCGTCCCTTCGACCGCAGCCGCCGGGGGCTCGTGCTGGGCGAGGGCGCCGCGATGTTCGTCCTGGAGGACACCGGCCGGGCCCGTCGCCGGGGCGCCCGCGTGTACGCGCGCATCCTCGGCTACGCCACCCGCGCCAACGCCTTCCACATGACGGGCCTGCGCGCGGACGGCCGCGAGATGGCGGAGGCCATCACCGCCGCCATGGACCAGGCCGAGCTCGGCCCCCAGGACCTCGACTACGTCAACGCCCACGGTTCGGGCACCAAGCAGAACGACCGCCACGAGACCGCGGCGGTCAAGACGAGCCTGGGCCACCGGGCGTTCGAGCTGCCGATGAGCTCCATCAAGTCGATGGTCGGCCACTCGCTGGGGGCCATCGGCTCCATAGAAGTGGCCGCCTGCGCCCTGGCCATCGAACGCGACGCCGTCCCGCCCACCGCCAACCTGCACGAGCGCGACCCCGAATGCGACCTGGACTACGTGCCCCTGACCGCGCGCGAGCAGAAGGTCCGCGCCGCGCTGTCGGTCGGCAGCGGGTTCGGAGGCTTCCAGAGCGCCATCGTGGTGGCCGCGCCGGGAGAGGCGGCGGTATGA	MRTMDVAITGIGVMAPGGAGREAFWDCIVSGRTATRRVTHFDPAGYRCQVAAEIDFDPAAHGLTPQQARRMDRAAQLAVVATDEALADSGFDTGGTDPGRIAVTVGNAVGCTTGLEEEYRVLSDDGRQWAVDHTFAVPQLYNYLVPSSIATEVAWRAGAEGPVSVVSSGCTSGIDALGCAAGLLAEGSADVVVAGSADAPISPITMACFDAIKATSTYNDDPQQACRPFDRSRRGLVLGEGAAMFVLEDTGRARRRGARVYARILGYATRANAFHMTGLRADGREMAEAITAAMDQAELGPQDLDYVNAHGSGTKQNDRHETAAVKTSLGHRAFELPMSSIKSMVGHSLGAIGSIEVAACALAIERDAVPPTANLHERDPECDLDYVPLTAREQKVRAALSVGSGFGGFQSAIVVAAPGEAAV	MSEQFQLQQLQEYLHALFAESLFAIYLYGSAVDGGLGPESDLDLLVVVTQPLTHVQRQQLAQALLTLSHPIGGLQRALEVTILLKEEVISGRYPLNYELQFGEWLREELVDGGELSAQNDPDISILLKKAHMHHRTLFGPDLTSWLDEIPDQQLWQAMADLYPSIVAHWDEDGDERNQILALCRIYFSLSLGEIVSKSHAAQWVIAQLEEKDQPVLQRMVQEYKGEMTKQDWPSQHQVLQPIVNFLSQHIETFFDKKGLKIKQ	160.84	gnl|BL_ORD_ID|2382|hsp_num:0	2754			111	240	spectinomycin; streptomycin
BGC0000222.1|FD-594_16 # 15166 # 16419 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGGAG;rbs_spacer=10bp;gc_cont=0.747	BGC0000222.1|FD-594_16 	15166	16419	+	Loose	750	109.383	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	29.85	3003463	protein variant model	G387D, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGACGGGCACGGGACGAAGGACTCCGCCGGCGCACCCGCCGCCGTCTTCACCGGGATCGGGGTCACCGCCCCCAACGGGCTCGGCACCGAGGAGTGGTGGTCCGCCACCCTGGCCGGCAAGAGCGGGATCGACTTCGTCAGCAGCTTCGACGCGCGCTCCTACCCCGCACAGCTCGCGGGAGAGGTCAGGGACTTCGACGCCGGCGCGTACCTCTCGCCCCGGATCGTCGTCGAGACCTCCAAGATGAGCCACTTCGCGCTGGCGGCCACCGCAATGGCCCTGGACGATGCCGCCGCCGACCTGACGCGGATACCGGAGTACGAGCGGGCGGTGATCACCGCGAACGCGTCCGGAGGCGCCGAATTCGGCCAGCGGGAACTGCAGAAGCTCTGGCGCGGCGGCCCCAGGGACGTCAGCCCCTACATGTCCATCGCCTGGTTCTACGCCGCGACCACCGGCCAGATCTCCATCGGCCACGGGATGCGCGGACCGTGCGGCGTCGTGGTCAGCGAGCAGGCGGGCGGACTGGACGCGCTGGGCCAGGCCCGGCGGGTGGTGCGCGGCGGCGCCCGGCTGGCTGTCACCGGCGGGACGGACTCCTCGCTCTCCCCGGCCGGGTACGTGTCGCAGCTGCCGACCGGGCACCTCACCACCGTCACCGACCCGGCGCGGGCCTACCTGCCCTTCGACGCCGCGGCATCGGGCTTCGTCCCCGGCGAGGGTGGCGCGATCCTGGTGATGGAGAACGGCACGACGGCGCGTGAGCGCGGCATCGGCGATCCGTACGGGGAACTCGCCGGCTACGCCGCCGCGTTCGACCCCCGCCCCGGCTCCGCGCGGCCCCCCGCGCTCGCCCGCTGCATCCGCGCGGCCCTCGACGACGCACGGCTGCGGCCCGAGGACATCGACGTCGTCTTCGCCGACGGGCACGGCACCGCGGAGCTCGACCGCCAGGAGTCGCAGGCGCTCGCCGGGGTCTTCGGACCGCGGGGCGTGCCCGTGACGGTGCCCAAGACCATGACCGGCAGGCTCTACGCGGGCGCCGGAGCCCTCGATGCGGCCGGCGCCCTGCTGGCGCTGCGCGACCAGGTCGTGCCGCCCACCGTCCACGTCACCGGCCCGGCCCCCGGGCACGCCCTGGACCTGGTCCTGGACCAGCCGCGCGAGCTTCCCCTGCGCACCGCCATGGTCATCGCCCGCGGACACGGCGGCTTCAACGCCGTGACCGTGCTGCGCCGGGCCCGCTGA	MSDGHGTKDSAGAPAAVFTGIGVTAPNGLGTEEWWSATLAGKSGIDFVSSFDARSYPAQLAGEVRDFDAGAYLSPRIVVETSKMSHFALAATAMALDDAAADLTRIPEYERAVITANASGGAEFGQRELQKLWRGGPRDVSPYMSIAWFYAATTGQISIGHGMRGPCGVVVSEQAGGLDALGQARRVVRGGARLAVTGGTDSSLSPAGYVSQLPTGHLTTVTDPARAYLPFDAAASGFVPGEGGAILVMENGTTARERGIGDPYGELAGYAAAFDPRPGSARPPALARCIRAALDDARLRPEDIDVVFADGHGTAELDRQESQALAGVFGPRGVPVTVPKTMTGRLYAGAGALDAAGALLALRDQVVPPTVHVTGPAPGHALDLVLDQPRELPLRTAMVIARGHGGFNAVTVLRRAR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	100.24	gnl|BL_ORD_ID|1968|hsp_num:0	1943			87	1245	isoniazid
BGC0000222.1|FD-594_17 # 16470 # 16727 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.686	BGC0000222.1|FD-594_17 	16470	16727	+	Loose	500	24.2534	RCP-1	52.17	3003563	protein homolog model	n/a	n/a	penam	antibiotic inactivation	RCP beta-lactamase	GTGAGCACATTCACCCTCGACGACCTCAGGACGATGCTGAGGGAGGGCGCCGGCGTCGACGATTCCGTGGACCTCGACGTGCCGATCCTGGACACCCCCTTCAGCAGCCTCGGATACGACTCCCTCGCCATGCTGGAGATCGCGGCCCGCATCGAGCAGCAGCTGGGGGTCCACGTCCCGGACGAGCTCGTCGAACGCCTGACGACCCCCCGCGCCGTTCTGGAGTACGTCGGCCGGCACCTCGCGGAGGTGGCCTGA	MSTFTLDDLRTMLREGAGVDDSVDLDVPILDTPFSSLGYDSLAMLEIAARIEQQLGVHVPDELVERLTTPRAVLEYVGRHLAEVA	MRFTATVLSRVATGLALGLSMATASLAETPVEALSETVARIEEQLGARVGLSLMETGTGWSWSHREDELFLMNSTVKVPVCGAILARWDAGRLSLSDALPVRKADLVPYAPVTETRVGGNMTLDELCLAAIDMSDNVAANILIGHLGGPEAVTQFFRSVGDPTSRLDRIEPKLNDFASGDERDTTSPAAMSETLRALLLGDVLSPEARGKLAEWMRHGGVTGALLRAEAEDAWLILDKSGSGSHTRNLVAVIQPEGGAPWIATMFISDTDAEFEVRNEALKDLGRAVVAVVRE	29.01	gnl|BL_ORD_ID|895|hsp_num:0	882			96	165	
BGC0000222.1|FD-594_19 # 17200 # 17658 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.725	BGC0000222.1|FD-594_19 	17200	17658	+	Loose	450	25.7942	aadA13	30.3	3002613	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGACGCAGATCCTCCTGCCCCTCGCCCTGATCGGCAGCGGCATGGCGGCGGGCGGCCTGATGATCGCCTCGCTGGGAGGCGCCCCCCTGCTGCTCAGCCTCCCCGCCGACCGCTACGTCCCCGTCCACCAGTTCCTGGTCACCCGCTTCGACCCGTTCATGCCGATCTGCATGGTCACCGCGATGCTGACCGACACCGCCGTCGCCGCCCTGGCCCACGACGCGACACGGGTGCCCGCGGGCGTCGCGGCCGTCCTGCTGCTCGGCGCGATCGTCGTCTCGCTCGCCAAGAACGTGCCCATCAACAAGTGGGTCGGCTCCCTGGAGCCGGGCGTCGTCCCGCCCGACTGGGAGCGGGTCGACCCCCGGGCGCGCTGGCGCAACTGGAACCTCGTCAGGACCGGGCTCGCGGTCACCGCGCTCCTGGCCAACGCAACCGCAGCGGCACTCGCCCTGTGA	MTQILLPLALIGSGMAAGGLMIASLGGAPLLLSLPADRYVPVHQFLVTRFDPFMPICMVTAMLTDTAVAALAHDATRVPAGVAAVLLLGAIVVSLAKNVPINKWVGSLEPGVVPPDWERVDPRARWRNWNLVRTGLAVTALLANATAAALAL	MRDSVTAEISTQLSKVLSVIEHHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTARLDDTTRRALFNDLLEVSAFPGESEILRAIEVTIVVHEDIMPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLIKALNETLKLWNSQPDWAGDERNVVLTLSRIWYSAATGKIAPKDVAANWAMEHLPAQHQSVLLEARQAYLGQEEDRSVLRADKLEEFIHFMKSEITKVLGNDV	57.36	gnl|BL_ORD_ID|1908|hsp_num:0	2087			150	348	spectinomycin; streptomycin
BGC0000222.1|FD-594_20 # 17679 # 18428 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAGA;rbs_spacer=4bp;gc_cont=0.713	BGC0000222.1|FD-594_20 	17679	18428	+	Loose	700	26.5646	tet(Z)	27.78	3000183	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACCTGTCACTGGACGGGCAGCACGTGCTCGTCACCGGCGGCACCCGCGGCATCGGCCGCGCCGTGGTCCTGGCCCTGGCCGGCGCGGGCGCCGACGTCATCACCTGCCACCGGCAGGACTCCGAGGAGGCGCAGAGCCTCGCCCGTGAGCTCAAGGAACTCCCCGGCGACCACCACCTGGTCAAGGCCGACGTGGGCGACCCCGACGACGTCGAACGACTGCTGGACGCGTGCAAGAGCCGGTTCGGCACGCTCGACACCGTGGTCAACAACGCGGGCGTCATCTCCCACGTGCCCTTCGCCGAACTGCCCCTGGCCGAGTGGCAGCGGATCATCGCCGCCAACCTCACCGCCCCGTTCCTGGTCGTGCAGAAGGCGCTGCCGCTGCTCTCGGAGAACGCCTCGATCGTCAACATCGGCTCCCGCGTCGCCACCGTGGGACTGCCCCTGCGCGCCCACTACACCGCGAGCAAGGCCGGTGTGATCGGGCTGAGCAGGTCGCTCGCCAAGGAGCTGGGCCCCCGCGGCGTCCGCGTCAACGTCGTCGCCCCCGGCGTGATCGAGACCGAGGAGGCGGCCAGGCTCGACCCGCAGGAGTACGAGGCGCTCCAGCAGCGCTACCGCCACATGACCGCCCTGGGCCGGCTCGGCCTGCCCGCCGAGGTCGCGTCGGTGGTCACCTTCCTCGCAAGCCCCGCGTCGGCGTACCTGACCGGCGAGATCATCCACGTCGACGGAGGGATCTGA	MNLSLDGQHVLVTGGTRGIGRAVVLALAGAGADVITCHRQDSEEAQSLARELKELPGDHHLVKADVGDPDDVERLLDACKSRFGTLDTVVNNAGVISHVPFAELPLAEWQRIIAANLTAPFLVVQKALPLLSENASIVNIGSRVATVGLPLRAHYTASKAGVIGLSRSLAKELGPRGVRVNVVAPGVIETEEAARLDPQEYEALQQRYRHMTALGRLGLPAEVASVVTFLASPASAYLTGEIIHVDGGI	MLITATLDAAGLGLVMPILPTLLDQVGAPDDMIPLHVGLLTALYAIMQFLCAPILGRLSDRFGRRRVLVASLAGATIDYLVLALTDTLWVFYLARAVAGITGATNAVTATVIADITPPDQRAKRYGWLGACYGGGMIAGPAIGGLFGGVSPHLPFLVAAALAGITLVLSASLLRETRPPGSNGSHAQQPGTAKRTAVPGMLILLAVFGIVQFIGQAPGSTWVLFTQQRLDWNPVEVGVSLSIFGMVQVFVQAALTGRIVSRIGETRAILVGIAADAIGLIGLALIASTWAMLPILAALGLGSITLPALQTLLSRRAPEQQQGRLQGTLASLNSLTSIIGPVTFTGIFALTRTNADGTLWICAAALYVLCALLMIRETCASRRSR	64.84	gnl|BL_ORD_ID|1793|hsp_num:0	1885			195	465	tetracycline
BGC0000222.1|FD-594_22 # 18756 # 19088 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.730	BGC0000222.1|FD-594_22 	18756	19088	+	Loose	1020	24.6386	tlrC	33.9	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGAGCGGCGAGGTCCGTGTGATCGTCTACTGCCGGGCCCCCGAGCAGGGCACCGCCCCGGTCGAGGCCGCCTTCCACAGCATCAACGAGGACCTGGCCGGGGTGCCCGGCCTGCTCCGCAGCGAACTGCTCGGCTCCACCCTCGACGGCGAGGACCGCACCCTGGCGGTCCTGAGCCACTGGAAGGACACCGCTTCCTTCCGCGCCTGGGAGCAGGGGGCCGCGCACCGCGCGCAGACCTCCCCGCTGCGCCGGTACCAGGACCGCGAGAGCGGCAGCCGGCACTACGGGATCTACGAGGTCCTCTCGTCCTTCGCCCCCGACCGCCCCTGA	MSGEVRVIVYCRAPEQGTAPVEAAFHSINEDLAGVPGLLRSELLGSTLDGEDRTLAVLSHWKDTASFRAWEQGAAHRAQTSPLRRYQDRESGSRHYGIYEVLSSFAPDRP	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	20.07	gnl|BL_ORD_ID|1841|hsp_num:0	1997			375	537	lincomycin; tylosin; mycinamicin
BGC0000222.1|FD-594_23 # 19100 # 19348 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	BGC0000222.1|FD-594_23 	19100	19348	+	Loose	250	23.8682	arr-2	39.02	3002847	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGCGGCCGGAGAGGAAGCGGGCACTGCGCCGCCTGGCGCGTGCGCTGGGACTGAGCCTGTGCGACGGGCTTCGCGTCCTGGGATCGCTGTACGTCGTCCAGCCTCCGTGGCCGCCCTACGACGACAGGACCCTGGCCGAGCCCCCGCCGGGCTCTCCCGAGCGACTCGACCCCGGCGCCCCGGCGTCGCCGGTCGAACGGCAGCTGTTCGACCAGCTCGGCCGGGACCTGCGGTGGCCCGCGCCGTAA	MRPERKRALRRLARALGLSLCDGLRVLGSLYVVQPPWPPYDDRTLAEPPPGSPERLDPGAPASPVERQLFDQLGRDLRWPAP	MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKKFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED	54.67	gnl|BL_ORD_ID|1021|hsp_num:0	1116			195	315	rifampin; rifaximin; rifabutin; rifapentine
BGC0000222.1|FD-594_24 # 19401 # 20444 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGAGA;rbs_spacer=13bp;gc_cont=0.720	BGC0000222.1|FD-594_24 	19401	20444	+	Loose	1200	43.1282	arnA	23.72	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCACCGTGCCGCCCCGTCCCGCACCGTGCTCGTCACCGGCGCCGCCGGCTTCATCGGCGCCAACTTCGTCCACTACTGGCGCGCCGCACACCCCGGCGACACCGTCGTCGCCCTGGACGCCCTCACCTACGCCGGCAACGAGGAGAACCTCGCGACCGTACGGGACGGGATCGTCTTCGTGCACGCCGACATCGCCGACGGCGCCCGCATGTCACGGGTCCTGCGCGAGCACCGGGTCGAGGTGGTGGTGAACTTCGCCGCCGAATCCCACAACAGCCTCGCCGTCCTCGACCCCGCACGGTTCTTCCGCACCAACGTCCTGGGCACCCAGGCGCTCCTGGAGGCGTCCCTGCGCGCCGGCGTCGAGCGCTTCCACCACATCTCGACGTGCGAGGTGTACGGGGACCTGGCGCTCGACAGCCCCGACGCCTTCCGCGAGGACCGCGCCTACCGGCCCCGCACCCCGTACAACGCCAGCAAGGCCGGGGCCGACCACGCGGTGCGCGCCTACCACGAGACCTTCGGCCTGCCCGTCACCCTCACCAACTGCGCCAACAACTACGGGCCCTACCAGTTCCCGGAGAAGGTGATCCCGCTGTTCGTCACCAACGCGCTGCTCGGCAGACCGCTGCCGGTGTACGCCTCCCGGGACCACCGGCGGGAGTGGATCCACGTGGACGACCACTGCCGTGCCATCGACGCCGTGCTGACGGGCGGCGAGCCCGGGCGGACCTACCACGTGGGCAGCGGTGTGGAAGCGAGCGTGCAGGACATCGCCGACGCGGTGCTCGCGGAACTCGGCCTGCCCGCCTCCCTGCAGACCACGGTGGCGGACCGGCCGGGCCACGACCGCCGCTACCTGCTGGACTCCGGCCTGATCAGGCGGACGCTCGGCTGGCGGCCCACCGTCGAGTTCGCGGAGGGCCTGGCCCGGACCATCCGCTGGTACCGCTCCAACCCCACCTGGTGGGAGCCCCTGCTGGAGCGGCGCCCGGTGACGGAGGAGTCCGTCTGGCAGCAGCCGGAGGTCTCGTCGCGATGA	MHRAAPSRTVLVTGAAGFIGANFVHYWRAAHPGDTVVALDALTYAGNEENLATVRDGIVFVHADIADGARMSRVLREHRVEVVVNFAAESHNSLAVLDPARFFRTNVLGTQALLEASLRAGVERFHHISTCEVYGDLALDSPDAFREDRAYRPRTPYNASKAGADHAVRAYHETFGLPVTLTNCANNYGPYQFPEKVIPLFVTNALLGRPLPVYASRDHRREWIHVDDHCRAIDAVLTGGEPGRTYHVGSGVEASVQDIADAVLAELGLPASLQTTVADRPGHDRRYLLDSGLIRRTLGWRPTVEFAEGLARTIRWYRSNPTWWEPLLERRPVTEESVWQQPEVSSR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	52.42	gnl|BL_ORD_ID|1513|hsp_num:0	1643			1206	1950	polymyxin B
BGC0000222.1|FD-594_25 # 20441 # 21508 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.698	BGC0000222.1|FD-594_25 	20441	21508	+	Loose	300	25.7942	dfrA17	58.33	3002860	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAAGGCTCTGGTTCTGGCCGGAGGCACCGGCTCACGGCTGCGGCCCATCACGCACACCTCGGCCAAGCAGCTCGTCCCCATCGCCAACAAGCCGGTGCTGTTCTACGGCCTGGAGGCCATCCGCGACAGCGGCATCCGCGACGTCGGGATCATCATCGGCGAGACGGGCGCCGAAGTACGCGGCGCGGTGGGCGACGGGTCCCGGTTCGGCCTGTCCGTGACCTACATCCCCCAGGAGGCGCCCCTGGGCCTGGCGCACTGCGTGCTCATCGCCCGCGAGTTCCTCGGGGACGACGCGTTCCTGATGTACCTCGGCGACAACTTCGTCATCAACGGCATCCGCGGCTTCGTCGACGAGTTCCGCTCCCGGCGCCCGGAAGCCCAGCTCCTGCTGACGAAGGTCGCCGACCCCACGCAGTTCGGCGTGGCCGAACTGGACGTGGGCGGCAGGGTGATCGGGGTGGCGGAGAAGCCGAGCCGCCCCAAGAGCGACCTGGCCCTGGCGGGGATCTACATGTTCACGCCCGTCATCCACCCGATCGTGGCCGAGCTGCGGCCCGGCAGGCGGGGCGAACTGGAGATCACCGACGCCATCCAGGAGCTGATCCTCCGGCGGGCGGACGTCACCTCGCACGTCATCACCGGCTACTGGAAGGACACCGGCAAGGTCGAGGACATGCTGGAGTGCAACCGCATGGTGCTGGAGGGCCTCGCTCCGCGCATGTCCGGGGCGGTGGACGGCGAGAGCGAGATCATCGGGCGGATGGAGATCGCCGAGGACGCGGTCGTCGTACGGTCCCGGCTCGTGGGACCGCTGTCCATCGGCCCGGGCGCGGTGGTCACCGACAGCTACGTGGGCCCGTTCACGTCGGTGGGGCCCGGCTGCCGGCTGGACCGGACCGAGATCGAGTACTCGATCGTCATGGACCGCTCCTCCGTCAGCGGCGTGGGCCGGATCCACAACTCGCTCATCGGCAAGGACGTCGACATCTCCCCGTCCGCCTCCGCGCCGCGCGGCCACCAGCTGATCGTCGGCGACCACAGCCGGGTCCGTCTCGACCACTGA	MKALVLAGGTGSRLRPITHTSAKQLVPIANKPVLFYGLEAIRDSGIRDVGIIIGETGAEVRGAVGDGSRFGLSVTYIPQEAPLGLAHCVLIAREFLGDDAFLMYLGDNFVINGIRGFVDEFRSRRPEAQLLLTKVADPTQFGVAELDVGGRVIGVAEKPSRPKSDLALAGIYMFTPVIHPIVAELRPGRRGELEITDAIQELILRRADVTSHVITGYWKDTGKVEDMLECNRMVLEGLAPRMSGAVDGESEIIGRMEIAEDAVVVRSRLVGPLSIGPGAVVTDSYVGPFTSVGPGCRLDRTEIEYSIVMDRSSVSGVGRIHNSLIGKDVDISPSASAPRGHQLIVGDHSRVRLDH	MKISLISAVSENGVIGSGPDIPWSVKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYAVVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKADIIHLSTVHVEVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG	226.11	gnl|BL_ORD_ID|1050|hsp_num:0	1142			255	327	trimethoprim
BGC0000222.1|FD-594_26 # 21598 # 23091 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.721	BGC0000222.1|FD-594_26 	21598	23091	+	Loose	400	26.1794	QnrB56	32.31	3002769	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGACGCAGTCAAGCCGTCCGCGCGACCGGACGGGCGGAGGTGAACGAGGCGGGCGGCCGGACGGCACGGCGCTCCTGGCCGGCCGGTTCGGCCTGTCGGCGGCGACCACCGGCAATCCCCGGATCGCCACCGGGGACGTGCCGGCCTGGCTGGAGCGCGTCCGCCGGCACGGTGGCTTCGCCGTCTCCCGGATACCGTTCGCCGCACTCGACCAGTGGAGCTTCCACCCCGGAACCGGCAACCTCGGCCACAGCACCGGACGGTTCTTCACCGTCGAGGGCCTGCGGGTGAGCGGCGGGGACTGGGGCGCCGGCGGCTTCACCCAGCCGGTCGTCAACCAGCCCGAATCCGGGATCCTCGGGATCCTGGTCCGCGAGATCGACGGCGTTCTGCACCTGCTCATGCAGGCCAAGATGGAGCCCGGCAACACCGGACTGGTCCAGCTGGGACCCACCGTCCAGGCCACGCGCAGCAACTACACGCGCGCCCACCGCGGAGGCCCCACGCGGTACCTGGAGCACTTCACCGGCCCCGGCCGCGGCCGCGTCCTGGTGGACGTGCTCCAGTCCGAGCAAGGGGACAGCTTCTGGCACAAGCGCAACCGCAACATGGTGGTGGAGGTGTCCGGCGACATCCCCGTGCAGGACGGCCACCAGTGGATGACCCTGGGCCAGGTCCACGCGCTCATGGGAACCGCAAACCTGGTCAACATGGACGTGCGGACCGTGCTGTCCTGCCTGCCGCTGGAAGGCGGGGAAACGCCCGGCGACGACCTGCCCGGCACGAGCGCCGCCGGCTCCTTCCACCGGGCCCTGGCGCGGTCCCTCGGCCCTGGGGCCCGCGCGGTCCACGACGAGCTGGAGCTGCTCAGCTGGCTGACCGACCTGCGGACGGACAGCTCCGTGTCGGCCGGGCTGGTCCCGCTGCGCGGCCTGGCCGGCTGGCGGCAGGACGAGGACGCCATCGCCGAGGAGTCGGGCACCCGCCTGAAGGTCATCGCCGTCTCCGTCCGGGCCGGCACCAGGGAAGTCACCCGGTGGACCCAGCCCATGCTGGAGTTCCCCGGACAAGGAGTGGCGGCCTTCGTGGTCAAGCGCATCGGCGGCGTCCTCCACGTCCTGATGCAGGGCAAGGCCCAGCCCGGGATCCGGGACGCCGTCGAACTCGCCCCGACGGTGCAGTGCGTGTCGCGCAACTGGGAGGAAGTGCCGCCCCGTTCGCGGCCCCCGCTGCTCGACCACGTCCTGCGCGCCGGCAGCGCCCAGGTCCGGTTCGACGCGGTGCTCCCCGAAGAGGGCGGCAGGTTCTACCACCGCGACAACCGGTACCTCGTCATCGAGGCGGACGACGACTTCCCCGTCGCCGAGCCCGACACGATGCGGTGGGCGACACTGCACCAGCTCAAGACCCTGATGCGGTACGGCACCTACGTCAACGTCGAGGCACGCACCCTCATCGCCTGCCTGCAGTCCCTCTGGCCGGGGGAGCGGTGA	MTQSSRPRDRTGGGERGGRPDGTALLAGRFGLSAATTGNPRIATGDVPAWLERVRRHGGFAVSRIPFAALDQWSFHPGTGNLGHSTGRFFTVEGLRVSGGDWGAGGFTQPVVNQPESGILGILVREIDGVLHLLMQAKMEPGNTGLVQLGPTVQATRSNYTRAHRGGPTRYLEHFTGPGRGRVLVDVLQSEQGDSFWHKRNRNMVVEVSGDIPVQDGHQWMTLGQVHALMGTANLVNMDVRTVLSCLPLEGGETPGDDLPGTSAAGSFHRALARSLGPGARAVHDELELLSWLTDLRTDSSVSAGLVPLRGLAGWRQDEDAIAEESGTRLKVIAVSVRAGTREVTRWTQPMLEFPGQGVAAFVVKRIGGVLHVLMQGKAQPGIRDAVELAPTVQCVSRNWEEVPPRSRPPLLDHVLRAGSAQVRFDAVLPEEGGRFYHRDNRYLVIEADDDFPVAEPDTMRWATLHQLKTLMRYGTYVNVEARTLIACLQSLWPGER	MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG	219.91	gnl|BL_ORD_ID|1159|hsp_num:0	1263			483	678	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000222.1|FD-594_28 # 24121 # 25746 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGGAGA;rbs_spacer=4bp;gc_cont=0.750	BGC0000222.1|FD-594_28 	24121	25746	+	Loose	550	123.25	Nocardia farcinica rox	34.24	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGAAGAAGTGAGCACCCCCGTACTCGTCGTGGGCGGGGGGCTGGTCGGGCTGTCGGCGGCCGTGTTCCTCACCTGGCAGGGGCAGCGGCCCCTGCTGATCGAGCGTCACCCCGGCACGTCGCCCCACCCCCGTGCCCGCGGCGTGAACGTACGGGCGATGGAACTGTACCGGCAGGTCGGCCTTGAGGGCCTCATCCGGGACACCGAGTCCGGCCGCGCGCTCGCCGGCAACAGCGGCATCGTACGGATGGAGTCCCTGGCCGGACGGCAAGCACCCGGCTTCAGCCGGGACTACCTCGAAAGCGGTGCGGAAGACGTCAGCCCCACCGGATGGACCCTGTGCGAGCAGGACGAGCTGGAGCCGCTGCTGCGGGAGCGCGCCGAGGAGAGCGGCGCCGACCTGCGCTTCGGGCACGAGCTGGTCGGCCACAGCCAGGACGCCGACGGCGTCACGGCCACCGTGCGCCGCCGCGACACCGGTGAGCAGTACACCGTACGGGCCGGCTACATGGTGGTGGCCGACGGCGCGGGCAGTCCCGTACGGGAGCGGCTCGGCATCACCCGCGACGGGCACGGCGTCCTGGCCCACTACCTGAACATCCACTTCCGCGCGGACCTCACCGAGCTGCTCGGCGAGCGGCGCTTCGTCATGGCGTACGTGCGCAACGCCGAGGTGACGGCCGGGCTGCTGCCCGTCAACAACACCGACCGGTGGCTCCTGCACGTGCCGCTGAGCCCGGAGGAGTACGCGCACCGGGACGGCTGGGGAGAGGAACGGTGCGAGGCGGCCGTGCGGGCCGCGGTGGGCGACGCGGGACTGCCGGTGAAGATCCTCGGGGCGCAGCCGTGGGAGGCGGCCGGACTGGTGGCCGCCGCGTTCCGCCGCGGCCGGGTCTTCCTCGCCGGGGACAGCGCCCACGTCATGCCGCCGACGGGCGCCTTCGGCTCGGGCACCGGCATCCAGGACGCCCACAACCTCGCCTGGAAACTGGCCATGGTCCTGCGCGGCGAGGCGGGGGCGGAGCTGCTCGGCACCTACGAGAGCGAGCGGGTTCCCGTGGCGCGGGCCACGGTGCGGCAGGCGGTGCTGCGTTCCCTGGACCGCCCCGGCCGTGACGAGCCCGTACCGGAAGGGGCGATCCTGCCCGACCACGTGGTGGCCCTGGAGTACCGCTACCCGGTGGGCGGCGCCGTCCCCGAGGACGTGCTGGCAGCGGAAGGCGGCGGGGGCCGGCCGGGCACGCGGGCCCCGCACCTGTGGCTGGAGCGCGACGGTGAGCGGATCTCCACGCTCGACCTCTACGACGGCCGGAGGACGGTCCTGGTGGCGGGCCCGCGGGGGCAGCGCTGGTACGAGGCGGCAGCCCGCCTCCTTCCGCCCGTGACGGCTCACCGGATCGGGGCCCACGGGCTCGCCGACCCCTCGGGGCGATGGGCCGGCGCGCACGGCGTCCCGTCCGACGGCGCCGTCCTCGTCCGCCCGGACGGCTTCGTCCTGGCTCGCTTCACCGGGGAGGACGCCCCCGGAACAGCTCCGGCGGAGGCTCTGAGCGCGCTGCCGGGCCTCCGGGCCGCCGCGGCCCCCGCCGCGGAATCCACGACCGGGTCCAGGAGGCCTGAATGA	MEEVSTPVLVVGGGLVGLSAAVFLTWQGQRPLLIERHPGTSPHPRARGVNVRAMELYRQVGLEGLIRDTESGRALAGNSGIVRMESLAGRQAPGFSRDYLESGAEDVSPTGWTLCEQDELEPLLRERAEESGADLRFGHELVGHSQDADGVTATVRRRDTGEQYTVRAGYMVVADGAGSPVRERLGITRDGHGVLAHYLNIHFRADLTELLGERRFVMAYVRNAEVTAGLLPVNNTDRWLLHVPLSPEEYAHRDGWGEERCEAAVRAAVGDAGLPVKILGAQPWEAAGLVAAAFRRGRVFLAGDSAHVMPPTGAFGSGTGIQDAHNLAWKLAMVLRGEAGAELLGTYESERVPVARATVRQAVLRSLDRPGRDEPVPEGAILPDHVVALEYRYPVGGAVPEDVLAAEGGGGRPGTRAPHLWLERDGERISTLDLYDGRRTVLVAGPRGQRWYEAAARLLPPVTAHRIGAHGLADPSGRWAGAHGVPSDGAVLVRPDGFVLARFTGEDAPGTAPAEALSALPGLRAAAAPAAESTTGSRRPE	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	114.38	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	1032	rifampin
BGC0000222.1|FD-594_29 # 25743 # 26438 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5bp;gc_cont=0.731	BGC0000222.1|FD-594_29 	25743	26438	+	Loose	519	36.1946	GOB-2	25.43	3004809	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	ATGAAGCTGTACCTGTTCCAGCTCGGCACCAACCCGGTCGGCGCGCCCGTGCCCGGCTACCTCGTCCGGCTCGACGACGGCACGAACGTCCTGGTCGACACCGGCTTCCCGCGCGACGCCGGGCCCGGGGCCTCCGTCCGCGTGGGGCCCGGCGAGGGGATCGAGGCGCGGCTCGCCGGCGTCGGGCTGCGGCCGCAGGACATCGGAGTGGTGGTGTGCACCCACCTGGACCCGGATCACGCCGGCAACCACGACCTCTTCCCCGAAGCGGAGTTCGTCGTCCAGCGCAGCCACTACGAGCTGGCGCGATCAGGCACGCTGGGCCGGCTGGACATGGCAAGGGCGAAGTGGGACCTGCCCCATCTGAAGTACCGGCTGGCCGAGGGCGACACCGAGCTCTTTCCCGGCCTCTTCCTCCTGGAGAGCCCGGGGCACGTCGAGGGCCACCAGTCGGTGCTGGTCCGGCTGCCCCGCTCGGGCGCCGTGCTGCTGGCGGCGGACGCCATCCCCTCGGCCGACCACCTCGACCCCGACGCGCGGGCCATGACCCCCTTCGACGTGGACGAGGCCGCCGTCCGCTCCAGCACGCGCAAGCTGGTCGAACGGGCGAGGGCGGAGAAGGCGCTGCTCGTCCACGGGCATGACGCGCAGCAGTGGGCGACGCTGCGGACGGGGCCCGGCGCGTACTACGACTGA	MKLYLFQLGTNPVGAPVPGYLVRLDDGTNVLVDTGFPRDAGPGASVRVGPGEGIEARLAGVGLRPQDIGVVVCTHLDPDHAGNHDLFPEAEFVVQRSHYELARSGTLGRLDMARAKWDLPHLKYRLAEGDTELFPGLFLLESPGHVEGHQSVLVRLPRSGAVLLAADAIPSADHLDPDARAMTPFDVDEAAVRSSTRKLVERARAEKALLVHGHDAQQWATLRTGPGAYYD	KEPENMPNEWNQAYEPFRIAGNLYYLGTYDLASYLIVTDKGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYADKADVDVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLN	91.67	gnl|BL_ORD_ID|2538|hsp_num:0	3603			66	531	
BGC0000222.1|FD-594_31 # 27825 # 29129 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.749	BGC0000222.1|FD-594_31 	27825	29129	-	Loose	700	55.8398	oleI	25.71	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCCCACCATCCTCATGGCCTCTCTGGCCGCCAGCGGTCATGTCAATCCGTTCGGTCCGGTCGCCGCCGAACTGACCGGCCGCGGCCACCGCGTGATCTGGTACACGGGCACCGCCTACGCGGACCGGGTGGCCCGGACGGGGGCGCAGTACGCGGCGCCGGAGGCGGGCGGGTTCACCGACCTGGACCGACTGACGGACGAGCACCCGGAATTCCTCGCGCTGCCGCCCGACGCCCGCGGCGCCTGGTTCGTCGAGAACGTGTTCGTCCGCCCGGTGCCGGGGCAGTACCAGGACCTCCGGGACCTCATGACCCGGCACCGGGCGGACGTCCTGCTCGCCGACTCCACGCTCGCCGCCGCCTCGCTCGTGCACGAGCTGGACCGCCGGCTGTGGGCGACGCTCAGCGTGGCGCCGCTGGCCGTCCCGGACCCCTGGGTGCCGCCGTTCGGGAAGGGCTGGCCGCCGGGCGGTCAGCCCTGGCGCCGGGCCCGCCGCTGGTACACCGAGACGACCGAACGCCGCCGGTTCCCCGGCCCGCTGCGCCGGATGAACGCCGTCCGCCGGAGCCTCGGAGTGCCGCCGGTGCGCACCAGCCCGTTCGACGCCAACCTCACCCCGTACCTGTACGCGCAGGCGACCGTTCCCGAGTTCGAGTACCCGCGCCGGCGGCTCCCCGGGCAGGTGAACTTCATCGGGCCGCTGCTTCCCGCTCCCCCGCCGCCGGGCCCCTTGCCGGCCTGGTGGCCCGAACTGGCCGAGGACCGGCCCGCGGTCCTGGTCACGCAGGGAACGGGTGCCCGCGACCTCGGCGAGCTCGTCGTACCGACCGTTCGTGCGCTGGCCGGAGCGGACATCACCGTCGTCGTCACCACGGGAGGCGCCTCGCACGAGGCGCTGCGGCCCGAGGTGCTGCCGCCCAACGTCCGGGTGGAGCCGTTCCTGCCGTACGAGAAGCTGATGCCGCGGCTCGACGCGATGGTGACCAACGGCGGCTACGGGACCGTACAGCTCGCGCTGGCGCACGGCGTCCCGATCGTGGCCGCCGGGAGGACCGAGGACAAACCCGAAGTGTGCGCGCGGGTCGCCTGGAGCGGCACCGGCATCGACCTGCGGCAGCAGCGCCCGCCGGTGCCCGCCCTCGCGAAGGCCGTGCACACCGTGCTCACCGACCCCCGCTACCGGCGGGCGGCCTCCGCGATGAGCACCGCCTTCGCCGCACGCCGAGCGCCGCGGGAGCTGGCGGTCCTGCTGGAGGAACTCATCGCCACCCGCCGCCCGGTGCTGGCGTCCGCACCCTTGTGA	MPTILMASLAASGHVNPFGPVAAELTGRGHRVIWYTGTAYADRVARTGAQYAAPEAGGFTDLDRLTDEHPEFLALPPDARGAWFVENVFVRPVPGQYQDLRDLMTRHRADVLLADSTLAAASLVHELDRRLWATLSVAPLAVPDPWVPPFGKGWPPGGQPWRRARRWYTETTERRRFPGPLRRMNAVRRSLGVPPVRTSPFDANLTPYLYAQATVPEFEYPRRRLPGQVNFIGPLLPAPPPPGPLPAWWPELAEDRPAVLVTQGTGARDLGELVVPTVRALAGADITVVVTTGGASHEALRPEVLPPNVRVEPFLPYEKLMPRLDAMVTNGGYGTVQLALAHGVPIVAAGRTEDKPEVCARVAWSGTGIDLRQQRPPVPALAKAVHTVLTDPRYRRAASAMSTAFAARRAPRELAVLLEELIATRRPVLASAPL	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	102.36	gnl|BL_ORD_ID|1684|hsp_num:0	1824			660	1170	oleandomycin
BGC0000222.1|FD-594_32 # 29262 # 30479 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=6bp;gc_cont=0.745	BGC0000222.1|FD-594_32 	29262	30479	-	Loose	525	30.0314	OKP-B-17	32.91	3002450	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGGCCCGCACGGTCTTCCGCAACGCAAAGGTCTTCGACGGCCACCGTGTCCGGAGTGATGACGACACCGTCGTCGTCCACGAGGGACGCATCGAGTCGGTCGGCCGGGGCCTCCCGGCGCCGGCCGGCAGCGAGGTGGTCGAGTGCGACGGAGGCACCCTGCTTCCCGGGCTCATCGACGCCCACACCCACATCGTCGGCCCCGCGCTCCGCCAGGCCCTGCTGTGGGGGGTCACCACCGAGCTGGACATGGCCAACTTCCCCGGGCCGATGGCCGACGCGAAGAAGGAGCAGGACGGCCCGCTCGGCTCCCGCGTCGCCGATCTCCGGTCGGCCTGCTGCGCCGCCACCGTCCCCGGCGGGCACGGCTCCGAACGGTTCCCGCACATCCCGACGCTCACCGAGCCCGAGGAGGCTCCCGGATTCGTCGACGCCCGCATCGCCGAAGGCTCCGACTACATCAAGATCCACTATGACGACGGCCAGCTCGCGGGCCGGCTGGAGGAGACCGAACTGCCCGTCATCCGGAAGGAGACGATGGCCGCGGTCATCGCCGCGGCGCGCGAGCGCGGCATGCTCACCCTCGTCCACACCGGTACGGTGCGGGCGGCGCTGGACGCCGTGGAGTCCGGCGCGCACGGCCTGGCCCATCTGCTCGTCGACCATGCGCCGGGGCGCGAGTTCGGAGAGGTGCTCGCACGGCACGGTGCCTTCGCGGTGCCCACGCTCAGCATGATCGAGCTGCTCTCCGGCAGCACGGAACTCGGCGCCCTCGCCGAGGAGCCGGGCGTCGCCGGCCACCTCACCCCCGAGGAACGTGAGCTCCTCGGCCGCCACCGGGCGGGCACCGCACGCCGGCTTCCCGTGGACCTGTCCGCCGCCATGGCCGCGGTCCGTTCGGCGCACGCCGCGGGGGTCCCCCTGCTGGCCGGCACGGACGCGGTGATGTGGCTGCACGGCATCGGCCTGCACCGGGAGCTGGAACTCCTGGTGCGCGCAGGGCTGACCCCGGGCGAGGCGCTGACCGCGGCGACCGCGACGCCCGCGGCGGTCTTCTCCCTGTCCGACCGGGGGCGGATCGCCCCCGGTCTGCGCGCGGACCTCCTGCTGGTCGACGGCGACCCCACCGCGGACATCCGGGCCAGCCGGGCGGTCCGGGGCGTGTGGAAGCGCGGGACCGGTGTGGAGCGGCAGCCCGGGGAGGCCCACGCCGGCTGA	MARTVFRNAKVFDGHRVRSDDDTVVVHEGRIESVGRGLPAPAGSEVVECDGGTLLPGLIDAHTHIVGPALRQALLWGVTTELDMANFPGPMADAKKEQDGPLGSRVADLRSACCAATVPGGHGSERFPHIPTLTEPEEAPGFVDARIAEGSDYIKIHYDDGQLAGRLEETELPVIRKETMAAVIAAARERGMLTLVHTGTVRAALDAVESGAHGLAHLLVDHAPGREFGEVLARHGAFAVPTLSMIELLSGSTELGALAEEPGVAGHLTPEERELLGRHRAGTARRLPVDLSAAMAAVRSAHAAGVPLLAGTDAVMWLHGIGLHRELELLVRAGLTPGEALTAATATPAAVFSLSDRGRIAPGLRADLLLVDGDPTADIRASRAVRGVWKRGTGVERQPGEAHAG	MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR	141.61	gnl|BL_ORD_ID|1534|hsp_num:0	1662			81	318	
BGC0000222.1|FD-594_33 # 30776 # 32278 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=12bp;gc_cont=0.747	BGC0000222.1|FD-594_33 	30776	32278	+	Loose	550	130.954	Nocardia farcinica rox	34.48	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCATCGGCGACCGGGGTTGTGGTGGTGGGAGCGGGGCCCGTGGGCCTGACGCTGGCGATCGAGCTCGCCAGGCGGGGCGTGGACTGCCGCATCGTGGACCGCAGGGGAGAGCCGCGTCCGGGAACGCGCGGCTGCAGCGTCTGGCAGCGCACCCTGGAGACGTTCGACCTGATGGGCCTGCCCATGGCGGACTTCCGCTCCCGGGCCGTGGCCTACCGGCGCCGGGTCTACCACCCCTTCGGGGAGCCGGAGCTGGCCGTGGAGCTCGGCGAGGACGAAGGCCCCTATCCGCTGCCCGTGCTGATCGGCCAGCAGGAGACCGAGCGGGCCCTGACCGGACGCTTGCGGGAGCTCGGCGTCGAAGTCGAACGAGGCCTGCGGGCCGTGGGCGTGGAACAGGACGCCGAGGGCGTGTCGCTGACACTGCAGCACGAGGAAGGGGCCCGGGAGGAGGTCCGGGCGGACTGGGTCGTCTCCGCGGAAGGCGCGCACAGCGTGCTGCGCGACGCGCTCGGCATCCGCTGGCGCACGACCCGGTTCGAGGGGACCCAGCTCGTCCAGGTGGACGCCGTGGCGCACGGGCTGCCCGGTGACGGCCCCGGAGAAGCACACCTGTATCTCACGGAGGACGGCTTCCTGGGGGACCTGCCGCTGCCCGGCGGGCGCCGCCGGCTGTTCGCCGCGGTCGCCGACCCCGACCCCGGGCACCGCCTCGACCCGTCCGTGCGCGAGGTCGAGGCCTACGTCCGCAAGCTCTCCGGCCGGGCGGGCGTACGGCTGGAGTCCCCCCTGCACAACTGGCGCGTCCGGTTGCACAACAGCGTCGCCGACACGTTCAGGCAGGGCCGCTGTCTCCTGGCCGGCGACGCCGCACGCACCGTCATGCCGGTCACCGCCCAGGGCATGAACACCGGCATCCAGGACGCCTTCAACCTGGGGTGGAAGCTCGCCGCCGTCGTGTCCGGAGCCCCCGACGCCCTGCTGGACACCTACAGCGCCGAGCGCCTGCCGGTGGCCCACGACCTGATCGCCCGCACCGAGCGTTCGTTCTGGGGCGGTGCCGGCACGCCGCCCACCGCCGAAGCCGTGGCCGCAGGGGTCCGCAAACAGCAGCGGGCGCGCTCCGAGCAGGCCGTCGACTACCGGGACAGCAAGCTCAGCCGGCAGTACGCGGAAAGCACCGGCCTGAGAGCGGGCGACCGCGCCCCGCAAGCGCCGCTGACCGGCAGCGACGGGGGCACCACGACCCTCTACGACGAGCTGCGCAGCGGCGACTGGGTGGCCGTCGCCACGACCCCGCTCACCGGCCTGCCGCCCGGCGTGCGCGGCGCGCAACTCGCCGGGGCGCCCGGCCGGGAGACGGCCGGCCCCTATGCCCTGGCTCCGGGCGAGTCGCTGCTGATCCGGCCGGACGGCTACATCGGCTGCCGGAGCGGACCCGGGCAGGGGGAGCCGTACACCCGCTACTTGGCGGACGTCCTCGGCGTCCTCGGCGGCTGA	MASATGVVVVGAGPVGLTLAIELARRGVDCRIVDRRGEPRPGTRGCSVWQRTLETFDLMGLPMADFRSRAVAYRRRVYHPFGEPELAVELGEDEGPYPLPVLIGQQETERALTGRLRELGVEVERGLRAVGVEQDAEGVSLTLQHEEGAREEVRADWVVSAEGAHSVLRDALGIRWRTTRFEGTQLVQVDAVAHGLPGDGPGEAHLYLTEDGFLGDLPLPGGRRRLFAAVADPDPGHRLDPSVREVEAYVRKLSGRAGVRLESPLHNWRVRLHNSVADTFRQGRCLLAGDAARTVMPVTAQGMNTGIQDAFNLGWKLAAVVSGAPDALLDTYSAERLPVAHDLIARTERSFWGGAGTPPTAEAVAAGVRKQQRARSEQAVDYRDSKLSRQYAESTGLRAGDRAPQAPLTGSDGGTTTLYDELRSGDWVAVATTPLTGLPPGVRGAQLAGAPGRETAGPYALAPGESLLIRPDGYIGCRSGPGQGEPYTRYLADVLGVLGG	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	105.71	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	1002	rifampin
BGC0000222.1|FD-594_34 # 32359 # 33168 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.720	BGC0000222.1|FD-594_34 	32359	33168	+	Loose	150	28.1054	nimD	27.27	3007106	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	ATGACCGGACCGGCGAAAGCGCCCGCCGACCGCACCTACGAGGTCACCCTTCCCGACACCCGCAGGATCGTGAGCCCGGAGCCCCACCAAGTGGCCGTGCTGTGGCGGGACGTGACCGGCAACGAGCTGTACGCCCGGGGCGCCGACGGTCTCGCGGCCGGCGACGTCGTCTTCGACGTGGGCGCGAACATCGGGCTCGCCGCCCTCTTCTTCACCGGGCTGGTGCCCGGCCTGCGGGTGTACGCCTTCGAACCCGCGGAGGACTGCTTCGCCTGCCTCAAGGAGAACGCCGCCCGCCACGCACCCGGCGTCACTCCGGTCCAGGCCGCCGTCGGTGCCCGAGAGGGAACCGCGGAACTGACCTACTACCCGCAGTCGCCGGCGCAGAGCAGCCTCTTCCCCGACGAGGACGAGGACCGCCGCAACAGCCTGGCCTACCTGGCCAACAGCGGCATCCACGGGGACAGCGCACGCGCCTTCCTGGCCGAGATGCACCAGGGACGCCGCTGCCCGGTCCGGGTCACCACGGTGGCCGCGGCCGTGGAGGAACACGCCGTGGACGAGATCGCGCTGCTGAAGATCGACGTCGAGCGGGCGGAACAGCACGTCCTGGACGGCATCGGCGACGCGTGCTGGCCCAGGATCCGCCGGGTCGTGGCCGAGGTCCACGACACGGACGGCCGGCTGGACGCCATCACCGGGCAGCTGACCCGCCGGGGCTTCGACGTCGAGACGGGCCAGGAACCGCTGCTCGCCGGGACCGACGTCCACATGCTGCTCGCCGTCAGAAGCGCCGTCAGAAGCCGCTGA	MTGPAKAPADRTYEVTLPDTRRIVSPEPHQVAVLWRDVTGNELYARGADGLAAGDVVFDVGANIGLAALFFTGLVPGLRVYAFEPAEDCFACLKENAARHAPGVTPVQAAVGAREGTAELTYYPQSPAQSSLFPDEDEDRRNSLAYLANSGIHGDSARAFLAEMHQGRRCPVRVTTVAAAVEEHAVDEIALLKIDVERAEQHVLDGIGDACWPRIRRVVAEVHDTDGRLDAITGQLTRRGFDVETGQEPLLAGTDVHMLLAVRSAVRSR	MFREMPRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMQGPKVDAILRNDKVSFCVVEQDEVKPAEFTTYFRSVIVFGKARILTDENEKRNALNLLADKYSHGEAGMEAEMAKGFNHLLMIEITVEQMTGKEAIELTRGRNGCS	164.02	gnl|BL_ORD_ID|4759|hsp_num:0	5779			12	402	metronidazole
BGC0000222.1|FD-594_35 # 33318 # 34484 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.738	BGC0000222.1|FD-594_35 	33318	34484	+	Loose	700	65.4698	oleI	23.19	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGAATCCTCATGACGTCGATCCCCGCCGCCGGCCACTTCACCCCCATGGTGCCGCTCGCCTGGGCCCTGCGCTCCGCGGGGCACGAGGTCGTGACCGTCGCCCAGCCGGAGCTGGTGCCGGTCGTACGGGCGGCGGGCCTGTGCGCGCAGCAGATCGGCGAGCCGGTCGAGCAACTCCTCGGCCTCCGGGGCCTCCTGCCGGACGACACGACCCCGATCGAGGCGTGGGGACGCGTGATCGACCCGATGTACGCGACCGCCGCCAGGACATGGGCCGCCCAGACGCGGCGCACGATCGACGCGTACATGGACTTCGCCCGGTCCTGGGAACCCGGCCTGATCGTCGCCGAGCCCTTCGAGTTCTCGGCCCGCCTCATGAGCGGCGTCCTGAAGGTGCCGCTGGTCCGCCACGGGATCGGCCTCACCGGCAAGGCCGAGCGCTTCGAGAGGGCCGCCGCCGAGGGGCTGGCTCCCACCGCGGGGCGGCTCGGGCTGGGTGCGGGCGCACCGCAGCCCGAGCTGGTCCTCGACACCTGCCCGCCCTCGTTCGGGTACGGGGAATCCACGGCGGCCCGGCCCATGCGCTACGTCCCCTACAACGGCACGGGCACCCTGCCCGGCTGGGTCCTCGAACCCCCCGGGGCCAAGCGGGTCTGCATCTCGCTGGGCACCCAGACCCTGGTGCTCAACGGAGTCCCGCTGCTCCGCAGGATCATCGAGGCGGTGGCCGGGATCGACGGGGCGGAGGCGGTCGTGGCACTCGCCGCGTCGGACCGGGAACGGCTGGGGCCGCTGCCCGGCGACGTCCGCGTCGTGGAGTCCCTGCCGCTGAACCTGATCCTCGGCCGTTGCGACGCCGTGATCCACCACGGAGGGGCCGGCAGTGCCCTGACGGCCACCGCGTACGGACTGCCCCAGCTGGTCGTGCCGCAGTTCCTCGACCAGTTCGAGTACGGCGACCGGCTGGCCGCCGCGGGCGCGGGCATCACCCTGGACACCGCCGACGGGCAGAACAGCGTGGAGGGCATCCGGCAAGCCGTCGTCGGTCTCCTCGGCGACCGCGCCTACGCGAAGGCGGCGCAAGGGCTGCGCGACGAGATGGCGGCCATGCCGTCGCCCGCCGGGCACGTCGCGACGCTGGAGCAACTGGCGGCGCGTGCCTGA	MRILMTSIPAAGHFTPMVPLAWALRSAGHEVVTVAQPELVPVVRAAGLCAQQIGEPVEQLLGLRGLLPDDTTPIEAWGRVIDPMYATAARTWAAQTRRTIDAYMDFARSWEPGLIVAEPFEFSARLMSGVLKVPLVRHGIGLTGKAERFERAAAEGLAPTAGRLGLGAGAPQPELVLDTCPPSFGYGESTAARPMRYVPYNGTGTLPGWVLEPPGAKRVCISLGTQTLVLNGVPLLRRIIEAVAGIDGAEAVVALAASDRERLGPLPGDVRVVESLPLNLILGRCDAVIHHGGAGSALTATAYGLPQLVVPQFLDQFEYGDRLAAAGAGITLDTADGQNSVEGIRQAVVGLLGDRAYAKAAQGLRDEMAAMPSPAGHVATLEQLAARA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	91.51	gnl|BL_ORD_ID|1684|hsp_num:0	1824			39	1269	oleandomycin
BGC0000222.1|FD-594_36 # 34577 # 35005 # -1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.697	BGC0000222.1|FD-594_36 	34577	35005	-	Loose	450	27.335	imiH	44.44	3003094	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGGAAGCGCGTGCACGGGATTTCGGCGAGCTGCGGAAGCTGGTCGAGGGCAGCTCGGCCGAGGAGGCCGAGGCGAAGGCGGCGGATTTCTACGGAGGTCCTGAAGAAACCCTGGACGTGCTCTTCGCGCTGTTCCAGGACTCGTTCGTCCCGGAGAACGCCTCGGGGGTAGCCGGCGAGTTCCAGTTCGACGTCACGACGCCGGCCGGGGTGCGGGAGTACACGGTCCTCGTGGCGGACGGCCGGTGCGAGACCCGCCGGGGCGCGAGCGCGTCGGCCACCGCCGTGACGGCCGTCGGGCTGGGGGACTTCCTGCTGCTGTCCACGGGGCAGACCAGCGGTTTCCACCTCAGCGCCGAGAAGCGGCTGACCACCCGGGGTGATCTGGGGGCCGCGATCGGCTTCAAGGACTGGTTCAGGCTCGGCTGA	MEARARDFGELRKLVEGSSAEEAEAKAADFYGGPEETLDVLFALFQDSFVPENASGVAGEFQFDVTTPAGVREYTVLVADGRCETRRGASASATAVTAVGLGDFLLLSTGQTSGFHLSAEKRLTTRGDLGAAIGFKDWFRLG	MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQLVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAAPQS	55.91	gnl|BL_ORD_ID|210|hsp_num:0	232			483	564	
BGC0000222.1|FD-594_38 # 36012 # 36419 # 1 # ID=1_38;partial=01;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.728	BGC0000222.1|FD-594_38 	36012	36419	+	Loose	275	28.4906	LEN-14	29.91	3002477	protein homolog model	n/a	n/a	penam; penem	antibiotic inactivation	LEN beta-lactamase	ATGACCGCGGGCCTGCTCACCACCGCGCACCGGCACAGCCGCATCGCCGGACTGGGCACGTACCGTCCTCGCCGCACGGTCACCAACAAGGAGATCTGCGAGCGCATCGACTCCACCGAGGAGTGGATCGAGAGCCGTTCCGGCATCGTCACCCGCCACTTCGCGTCGCCCGACGAGACCCTGCCGGCGATGGCCGCGGCAGCCGCCGCGAACGCCCTGACCCACGCGGGCCTGGAAGCGGGACAGATCGACTGCGTGATCGTGGCCGGCATGTCGAACCTGGTGCAGACACCACCCCTCGCCGTGGCCGTGGCCCACGCCCTGGGCGCACGGGGGGCGGCCGCGTTCGACCTCTCGGCGGCCTGCGCCGGCTTCTGCCACGCGCTCGCGGTCGCGGGCGACATGGTC	MTAGLLTTAHRHSRIAGLGTYRPRRTVTNKEICERIDSTEEWIESRSGIVTRHFASPDETLPAMAAAAAANALTHAGLEAGQIDCVIVAGMSNLVQTPPLAVAVAHALGARGAAAFDLSAACAGFCHALAVAGDMV	SLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSDNCAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRW	89.47	gnl|BL_ORD_ID|182|hsp_num:0	200			51	366	
